Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 62
Eckert & Ziegler sales grow in Q1
By
AuntMinnieEurope.com staff writers
Isotope technology firm Eckert & Ziegler recorded a 5% increase in sales in its first quarter.
May 9, 2017
Dynamic PET/MRI study spots vascular correlations
By
Jude Dineley
Correlation between vascular fraction parameters may help to guide future clinical trials involving the use of PET/MRI to assess tumor hypoxia, researchers from Germany and Slovenia have found.
May 3, 2017
Molecular imaging shines new light on heart disease
By
Wayne Forrest
European experts in molecular imaging expect the addition of cadmium zinc telluride digital detector technology, advanced quantification software programs, and novel radiotracers in SPECT and PET imaging will lead to major advances in research and clinical applications for cardiovascular disease.
May 2, 2017
Radiology in Peru: From infectious diseases to mummies
By
Mélisande Rouger
Imaging of tuberculosis and ancient mummies are two key areas of expertise among Peruvian radiologists, a special focus session revealed at ECR 2017. In a question-and-answer interview, Dr. Jorge Luis Guerrero Gil from Lima, Peru, outlines the main issues facing radiologists in his country.
April 20, 2017
Miniature x-ray detector shows clinical promise
By
Sarah Tesh
Scientists in France have developed a tiny x-ray detector at the tip of an optical fiber. By combining a nano-optical antenna with indirect detection methods, they have created a device that is only a few tens of microns in diameter, and it may have clinical applications.
April 19, 2017
Reduced FDG dose levels for PET/MRI show mixed results
By
Wayne Forrest
Even though a lower dose of FDG did not significantly affect lesion detection for most adult cancer patients undergoing a whole-body PET/MRI scan, German researchers recommend that clinicians stay with recommended levels to avoid artifacts, according to a study published in the
Journal of Nuclear Medicine
.
April 12, 2017
4 steps to develop hybrid imaging
By
Dr. Arturo Chiti
Hybrid imaging involves combining two imaging modalities, typically PET and CT, SPECT and CT, or PET and MRI. There are four steps to follow to ensure that hybrid imaging is used to its full potential, Dr. Arturo Chiti writes.
April 11, 2017
Ultrasound-induced drug uptake requires caution
By
Ian Randall
Ultrasound-activated microbubbles can be used to increase the cellular uptake of drugs in vivo, and this can be tracked by fluorescent dyes, but Dutch researchers found the results can be affected by the rate of the dye's intercellular diffusion and nuclear accumulation, plus other factors.
April 6, 2017
IBA Molecular forms Curium as new radiopharmacy player
By
Erik L. Ridley
Radiopharmacy vendor IBA Molecular has combined with recent acquisition Mallinckrodt Nuclear Medicine to form Curium, a new company with a mission to be a global developer, manufacturer, and supplier of SPECT, PET, and therapeutic radiopharmaceuticals.
April 5, 2017
Imanova receives cash boost to develop PET tracers
By
AuntMinnieEurope.com staff writers
Imanova has been awarded an additional 1Â million pounds of funding from the U.K. Medical Research Council for clinical evaluation of PET imaging tracers for mitochondrial dysfunction and synaptic loss in Alzheimer's and Parkinson's diseases.
April 2, 2017
Hybrid imaging: Collaboration's top priority for ESHI
By
Frances Rylands-Monk
As this month's first anniversary celebrations draw to a close for the European Society for Hybrid Medical Imaging (ESHI), its president has stressed that more collaboration and better education and training are vital for the future success of hybrid imaging.
March 28, 2017
PET agent wins positive CHMP opinion
By
AuntMinnieEurope.com staff writers
Molecular imaging diagnostics firm Blue Earth Diagnostics said it has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommending market authorization in the European Union (EU) for its Axumin (fluciclovine F-18) PET agent.
March 23, 2017
Previous Page
Page 62 of 122
Next Page